These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 10229705)

  • 21. Xenobiotic gene polymorphisms and susceptibility to multiple myeloma.
    Lincz LF; Kerridge I; Scorgie FE; Bailey M; Enno A; Spencer A
    Haematologica; 2004 May; 89(5):628-9. PubMed ID: 15136237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Xenobiotic-metabolizing enzymes and cancer risk: correspondence between genotype and phenotype.
    Pelkonen O; Raunio H; Rautio A; Lang M
    IARC Sci Publ; 1999; (148):77-88. PubMed ID: 10493250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of individual susceptibility in cancer burden related to environmental exposure.
    Bartsch H; Hietanen E
    Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):569-77. PubMed ID: 8781385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer.
    Gresner P; Gromadzinska J; Wasowicz W
    Lung Cancer; 2007 Jul; 57(1):1-25. PubMed ID: 17337085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia.
    Krajinovic M; Labuda D; Mathonnet G; Labuda M; Moghrabi A; Champagne J; Sinnett D
    Clin Cancer Res; 2002 Mar; 8(3):802-10. PubMed ID: 11895912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk.
    Brockmöller J; Cascorbi I; Kerb R; Roots I
    Cancer Res; 1996 Sep; 56(17):3915-25. PubMed ID: 8752158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic polymorphisms of xenobiotic-metabolizing enzymes influence the risk of pulmonary emphysema.
    Kukkonen MK; Hämäläinen S; Kaleva S; Vehmas T; Huuskonen MS; Oksa P; Vainio H; Piirilä P; Hirvonen A
    Pharmacogenet Genomics; 2011 Dec; 21(12):876-83. PubMed ID: 22027651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Genes and enzymes of the xenobiotic-metabolizing system in cancer pathology].
    Liakhovich VV; Vavilin VA; Gutkina NI; Laktionova IP; Makarova SI; Mitrofanov DV; Ostashevskiĭ VA; Chasovnikova OB
    Vopr Med Khim; 1997; 43(5):330-8. PubMed ID: 9446323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms in xenobiotic-metabolizing genes and the risk of chronic lymphocytic leukemia and non-Hodgkin's lymphoma in adult Russian patients.
    Gra OA; Glotov AS; Nikitin EA; Glotov OS; Kuznetsova VE; Chudinov AV; Sudarikov AB; Nasedkina TV
    Am J Hematol; 2008 Apr; 83(4):279-87. PubMed ID: 18061941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of polymorphisms in xenobiotic-metabolizing genes and DNA-repair genes on diepoxybutane-induced SCE frequency.
    Laczmanska I; Gil J; Karpinski P; Stembalska A; Kozlowska J; Busza H; Trusewicz A; Pesz K; Ramsey D; Schlade-Bartusiak K; Blin N; Sasiadek MM
    Environ Mol Mutagen; 2006 Dec; 47(9):666-73. PubMed ID: 17078101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic factors in individual responses to environmental exposures.
    Hirvonen A
    J Occup Environ Med; 1995 Jan; 37(1):37-43. PubMed ID: 7620941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review of studies of selected metabolic polymorphisms and cancer.
    d'Errico A; Malats N; Vineis P; Boffetta P
    IARC Sci Publ; 1999; (148):323-93. PubMed ID: 10493265
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome.
    Chacko P; Joseph T; Mathew BS; Rajan B; Pillai MR
    Mutat Res; 2005 Mar; 581(1-2):153-63. PubMed ID: 15725614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study on polymorphisms in metabolic enzyme genes, DNA repair genes and individual susceptibility to childhood leukemia].
    Zhu R; Xia Z
    Wei Sheng Yan Jiu; 2004 Sep; 33(5):635-8. PubMed ID: 15612500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic polymorphisms and oral cancer.
    Taniyama Y; Takeuchi S; Kuroda Y
    J UOEH; 2010 Sep; 32(3):221-36. PubMed ID: 20857816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A nomenclature system for metabolic gene polymorphisms.
    Garte S; Crosti F
    IARC Sci Publ; 1999; (148):5-12. PubMed ID: 10493244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of gene polymorphisms of phase II of xenobiotic biotransformation from glutathione-S-transferase and N-acetyltransferase families in susceptibility to lung cancer among Mayak workers].
    Rusinova GG; Azizova TV; Viazovskaia NS; Glazkova IV; Gur'ianov MIu; Osovets SV
    Radiats Biol Radioecol; 2014; 54(4):350-9. PubMed ID: 25775823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detoxification enzymes: cellular metabolism and susceptibility to various diseases.
    Silva M; Carvalho MDG
    Rev Assoc Med Bras (1992); 2018 Apr; 64(4):307-310. PubMed ID: 30133607
    [No Abstract]   [Full Text] [Related]  

  • 39. Genetic polymorphisms in xenobiotic metabolism.
    Smith CA; Smith G; Wolf CR
    Eur J Cancer; 1994; 30A(13):1921-35. PubMed ID: 7734203
    [No Abstract]   [Full Text] [Related]  

  • 40. Genetic polymorphisms and metabolism of endocrine disruptors in cancer susceptibility.
    Hatagima A
    Cad Saude Publica; 2002; 18(2):357-77. PubMed ID: 11923879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.